{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:35:58Z","timestamp":1790634958274,"version":"4.1.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Specialized Program of Research Excellence"},{"name":"National Cancer Institute","award":["P50CA278595"],"award-info":[{"award-number":["P50CA278595"]}]},{"DOI":"10.13039\/100007923","name":"UW Carbone Cancer Center","doi-asserted-by":"publisher","award":["P30CA014520"],"award-info":[{"award-number":["P30CA014520"]}],"id":[{"id":"10.13039\/100007923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rutgers Cancer Institute","award":["P30CA072720"],"award-info":[{"award-number":["P30CA072720"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The TMEM173\/STING protein is linked to therapeutic resistance in preclinical models of HNSCC (Head and neck squamous cell carcinoma). To evaluate STING as a biomarker, quantitative immunofluorescence (QIF) was performed on a tissue microarray (TMA) cohort of primary HNSCC (n\u2009=\u200972). Cytokeratin and 4,6-diamidino-2-phenylindole (DAPI) staining were used to differentiate between tumor or stromal compartments, and patient groups were dichotomized based on STING QIF scores. HNSCCs display variable STING protein levels in both tumor cell and stromal compartments. STING QIF score in tumor cells is associated with p16 positivity, with similar nonsignificant trends observed for stromal QIF values. In cohort 1, elevated STING levels in either tumor cells (P\u2009=\u2009.029) or stroma (P\u2009=\u2009.023) significantly improved DFS. These findings were validated in a second oropharyngeal HNSCC TMA cohort (n\u2009=\u200992) where borderline or significant differences in DFS were observed for elevated STING in tumor cells (P\u2009=\u2009.066) or the stroma (P\u2009=\u2009.028). A more detailed breakdown of failure patterns in cohort 2 revealed that elevated STING in tumor (P\u2009=\u2009.015) or stroma (P\u2009=\u2009.054) predicts local-regional control, and a trend for reduced distant failure was also observed for elevated stromal STING (P\u2009=\u2009.067). Local-regional recurrence was rare in HPV+ tumors and occurred only with low STING expression. In multivariate analysis, p16 was a significant predictor for local control, whereas elevated STING was of borderline significance (P\u2009=\u2009.051). These results suggest that STING protein levels in the tumor cell are a biomarker for predicting HNSCC local control after radiation therapy, and elevated STING in tumor stroma may be associated with a reduced risk of distant failure.<\/jats:p>","DOI":"10.1093\/jncics\/pkaf126","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T12:32:25Z","timestamp":1768653145000},"source":"Crossref","is-referenced-by-count":1,"title":["STING predicts patterns of failure in locally advanced head and neck squamous cell carcinoma"],"prefix":"10.1093","volume":"10","author":[{"given":"Tyler","family":"MacNeil","sequence":"first","affiliation":[{"name":"Department of Pathology, Yale School of Medicine , New Haven, CT,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7046-2276","authenticated-orcid":false,"given":"Thomas J","family":"Hayman","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Radiology, Yale University School of Medicine , New Haven, CT,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2586-2216","authenticated-orcid":false,"given":"Shengguo","family":"Li","sequence":"additional","affiliation":[{"name":"Biostatistics Shared Resource, Rutgers Cancer Institute , New Brunswick, NJ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9314-3187","authenticated-orcid":false,"given":"Myrto","family":"Moutafi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yale School of Medicine , New Haven, CT,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0931-4906","authenticated-orcid":false,"given":"Sandra","family":"Martinez-Morilla","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yale School of Medicine , New Haven, CT,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis A","family":"Vathiotis","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yale School of Medicine , New Haven, CT,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Wisconsin School of Medicine and Public Health , Madison, WI,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M","family":"Harari","sequence":"additional","affiliation":[{"name":"Department of Human Oncology, University of Wisconsin School of Medicine and Public Health , Madison, WI,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4660-1859","authenticated-orcid":false,"given":"Barbara","family":"Burtness","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yale University School of Medicine , New Haven, CT,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0356-7478","authenticated-orcid":false,"given":"Hao","family":"Liu","sequence":"additional","affiliation":[{"name":"Biostatistics Shared Resource, Rutgers Cancer Institute , New Brunswick, NJ,","place":["United States"]},{"name":"Department of Biostatistics and Epidemiology, Rutgers School of Public Health , Piscataway, NJ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8336-8000","authenticated-orcid":false,"given":"Randall J","family":"Kimple","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Wisconsin School of Medicine and Public Health , Madison, WI,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5820-4397","authenticated-orcid":false,"given":"David L","family":"Rimm","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yale School of Medicine , New Haven, CT,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9408-1865","authenticated-orcid":false,"given":"Joseph N","family":"Contessa","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Rutgers University School of Medicine , New Brunswick, NJ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"2026051013513857600_pkaf126-B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026051013513857600_pkaf126-B2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"2026051013513857600_pkaf126-B3","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1200\/jco.21.02198","article-title":"Pembrolizumab alone or with chemotherapy for recurrent\/metastatic head and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by programmed death ligand-1 combined positive score","volume":"40","author":"Burtness","year":"2022","journal-title":"J Clin Oncol"},{"key":"2026051013513857600_pkaf126-B4","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1093\/jnci\/djac163","article-title":"Clinical trial development in TP53-mutated locally advanced and recurrent and\/or metastatic head and neck squamous cell carcinoma","volume":"114","author":"Rodriguez","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"2026051013513857600_pkaf126-B5","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat Immunol"},{"key":"2026051013513857600_pkaf126-B6","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"key":"2026051013513857600_pkaf126-B7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"key":"2026051013513857600_pkaf126-B8","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1038\/s41467-021-22572-8","article-title":"STING enhances cell death through regulation of reactive oxygen species and DNA damage","volume":"12","author":"Hayman","year":"2021","journal-title":"Nat Commun"},{"key":"2026051013513857600_pkaf126-B9","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1158\/0008-5472.Can-18-1972","article-title":"STING promotes homeostasis via regulation of cell proliferation and chromosomal stability","volume":"79","author":"Ranoa","year":"2019","journal-title":"Cancer Res"},{"key":"2026051013513857600_pkaf126-B10","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1093\/jnci\/dji427","article-title":"Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis","volume":"97","author":"McCabe","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"2026051013513857600_pkaf126-B11","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/nm791","article-title":"Automated subcellular localization and quantification of protein expression in tissue microarrays","volume":"8","author":"Camp","year":"2002","journal-title":"Nat Med"},{"key":"2026051013513857600_pkaf126-B12","doi-asserted-by":"publisher","first-page":"e0187532","DOI":"10.1371\/journal.pone.0187532","article-title":"STING expression and response to treatment with STING ligands in premalignant and malignant disease","volume":"12","author":"Baird","year":"2017","journal-title":"PLoS One"},{"key":"2026051013513857600_pkaf126-B13","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1200\/jco.2011.38.4099","article-title":"Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer","volume":"30","author":"Gillison","year":"2012","journal-title":"J Clin Oncol"},{"key":"2026051013513857600_pkaf126-B14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ijrobp.2016.05.026","article-title":"Prognostic value of p16 status on the development of a complete response in involved oropharynx cancer neck nodes after cisplatin-based chemoradiation: a secondary analysis of NRG Oncology RTOG 0129","volume":"96","author":"Galloway","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026051013513857600_pkaf126-B15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1200\/jco.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN cCancer Research Group trial (E3311)","volume":"40","author":"Ferris","year":"2022","journal-title":"J Clin Oncol"},{"key":"2026051013513857600_pkaf126-B16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1200\/jco.2016.68.3300","article-title":"E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx- ECOG-ACRIN Cancer Research Group","volume":"35","author":"Marur","year":"2017","journal-title":"J Clin Oncol"},{"key":"2026051013513857600_pkaf126-B17","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1200\/jco.19","article-title":"Phase II evaluation of aggressive dose de-escalation for adjuvant chemoradiotherapy in human papillomavirus-associated oropharynx squamous cell carcinoma","volume":"37","author":"Ma","year":"2019","journal-title":"J Clin Oncol"},{"key":"2026051013513857600_pkaf126-B18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/s0140-6736(18)32779-x","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"2026051013513857600_pkaf126-B19","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/jnci\/djaa184","article-title":"Precision radiotherapy: reduction in radiation for oropharyngeal cancer in the 30 ROC trial","volume":"113","author":"Riaz","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"2026051013513857600_pkaf126-B20","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.ijrobp.2024.08.014","article-title":"Interim futility results of NRG-HN005, a randomized, phase II\/III non-inferiority trial for non-smoking p16+ oropharyngeal cancer patients","volume":"120","author":"Yom","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["JNCI Cancer Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jncics\/advance-article-pdf\/doi\/10.1093\/jncics\/pkaf126\/66540377\/pkaf126.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncics\/article-pdf\/10\/2\/pkaf126\/66540377\/pkaf126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncics\/article-pdf\/10\/2\/pkaf126\/66540377\/pkaf126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T17:51:43Z","timestamp":1778435503000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jncics\/article\/doi\/10.1093\/jncics\/pkaf126\/8438352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jncics\/pkaf126","relation":{},"ISSN":["2515-5091"],"issn-type":[{"value":"2515-5091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,1,22]]},"article-number":"pkaf126"}}